EXHIBIT No. 11 Applied Bioscience International Inc. And Subsidiaries Computation Of Earnings Per Share (in thousands, except share data) Three Months Ended March 31, ---------------------------- 1995 1994 ----------- ----------- Primary Earnings per Share Income from continuing operations $ 436 $ 556 Loss from discontinued operations - (104) ----------- ----------- Net Income $ 436 $ 452 =========== =========== Weighted average number of shares of common stock outstanding during the period 28,173 28,123 Common stock equivalents assuming exercise of stock options (a) 257 263 ----------- ----------- Weighted average common and common equivalent shares outstanding 28,430 28,386 =========== =========== Primary earnings per common share: Continuing Operations $ 0.02 $ 0.02 Discontinued Operations (0.00) (0.00) ----------- ----------- Primary earnings per share $ 0.02 $ 0.02 =========== =========== Fully Diluted Earnings per Share Income from continuing operations $ 436 $ 556 Loss from discontinued operations - (104) ----------- ----------- Net Income $ 436 $ 452 =========== =========== Weighted average number of shares of common stock outstanding during the period 28,173 28,123 Common stock equivalents assuming exercise of stock options (a) 261 291 ----------- ----------- Weighted average common and common equivalent shares outstanding 28,434 28,414 =========== =========== Fully diluted earnings per common share: Continuing Operations $ 0.02 $ 0.02 Discontinued Operations (0.00) (0.00) ----------- ----------- Fully diluted earnings per share $ 0.02 $ 0.02 =========== =========== (a) In the calculation of common stock equivalents, stock options are assumed to be exercised at the beginning of the period. The proceeds from the options exercised are assumed to be used to purchase common stock at (i) the average market price during the period for primary earnings per share and (ii) the higher of the average or last market price during the period for fully diluted earnings per share.